Ping An Biomedical Co., Ltd. balance sheet

At the end of fiscal 2025, Ping An Biomedical Co., Ltd. had total assets of $9.6m, total liabilities of $3.3m and shareholders' equity of $6.4m. It held $164,697 in cash against $1.4m of debt: net debt of $1.2m.

Balance sheet

US$ thousands unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Ping An Biomedical Co., Ltd.: balance sheet, annual
Fiscal year	2023Sept 2023	2024Sept 2024	2025Sept 2025
Cash and equivalents	81	19	165
Receivables	—	5,763	2,378
Inventory	—	18	62
Total current assets	—	7,597	8,948
Total assets	—	8,101	9,610
Accounts payable	—	2,145	1,322
Deferred revenue (current)	—	238	10
Total current liabilities	—	9,060	3,242
Short-term debt	—	1,425	1,405
Total debt	0	1,425	1,405
Total liabilities	—	9,125	3,255
Shareholders' equity	−803	−1,024	6,355
Net debt (negative = net cash)	−81	1,406	1,240
Shares outstanding	—	18m	21m

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

Compare with peers

Head to head: NTRP vs PASW PASW vs XELB PASW vs UZX

More: Consumer Discretionary sector, rankings of US companies

Figures from Ping An Biomedical Co., Ltd.'s SEC filings (10-K and 10-Q). How we read and check them: methodology and data sources. Not investment advice. Back to Ping An Biomedical Co., Ltd.